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Abstract
Introduction
The relationship between obesity and breast cancer has been extensively investigated. However, how obesity and
breast cancer interplay to affect mortality and life expectancy of women in the United States has not been well studied.
Methods
We used data from the National Health Interview Survey, 1997–2000. Our sample included nonsmoking, nonpregnant
women who reported a body mass index of at least 18.5 kg/m2 and no cancer other than breast cancer at the time of the
survey. A survival model with Gamma frailty and Gompertz baseline was used to estimate relative risks of total
mortality and project life years lost associated with breast cancer by obesity status and age.
Results
Breast cancer increased risk of mortality depending on degree of obesity and decreased life years by 1 to 12 years
depending on race, age, and obesity status. Relative risks for death increased with degree of obesity. Obese women
under age 50 across all racial groups were predicted to lose the most life years; racial groups other than whites and
blacks lost the most life years (11.9 y), followed by whites (9.8 y) and blacks (9.2 y).
Conclusion
The number of life years lost associated with breast cancer was more marked for more obese than for less obese women
and for women under age 50 and women aged 70 or older than for women aged 50 through 69. Public health initiatives
should put more emphasis on the prevention and control of obesity for these target populations.

Introduction
Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of death among women
(1). Obesity is a known risk factor for postmenopausal breast cancer (2,3) but may be inversely related to
premenopausal breast cancer incidence (4). Obesity is also associated with increased all-cause mortality (5–7).
However, it is unclear how obesity and breast cancer interplay to affect mortality and life expectancy of adult women.
Some studies have focused on obesity in relation to breast cancer incidence (8–10); others have explored the
relationship between obesity and mortality from breast cancer (11–13). Few studies have examined life expectancy
associated with breast cancer (14,15). To our knowledge, no studies have considered this association in relation to body
mass index (BMI). Our study is the first to consider BMI in the relationship between breast cancer and mortality rate
as well as life years lost associated with breast cancer. Our study used both life years lost and mortality rate, which are
accepted outcome measures of population health (16,17).
The goal of this study is to investigate the mortality risks associated with breast cancer according to BMI level and race
and to predict life years lost among women in the United States. We used data from a national probability sample of
the US population and a class of survival model. The projection of life years is computed on the basis of mortality
estimates and the observed characteristics of the sample as a snapshot of their life span. This approach is not restricted
by the length of mortality follow-up and the observed mortality rates, and thus provides an alternative to the life table
approach (14).

Methods
Data and the sample
Data from the National Health Interview Survey (NHIS) and the NHIS Linked Mortality Public-Use Files were used in
this study (18). The NHIS is a cross-sectional household interview survey providing health information on the civilian,
noninstitutionalized household population of the United States. The NHIS consists of 3 major components: Family,
Sample Adult, and Sample Child. From each family, 1 sample adult (aged 18 years or older) and 1 sample child (if any
children under age 18 are present) are randomly selected, and information on each is collected from the sample adult
core and the sample child core questionnaires. The Sample Adult Data Files from 1997 to 2000 were used and linked to
the data in the NHIS Linked Mortality Public-Use Files by personal identification numbers. Mortality data followed up
the NHIS sample from the date of interview through December 31, 2006.
We focused on female breast cancer; therefore, our sample included only women. The sample exclusion criteria were
the following: 1) women with any missing data; 2) women who had smoked more than 100 cigarettes in their entire
life, because analyses can be confounded by illnesses associated with smoking (6,7); 3) women pregnant at the time of
survey, because BMI levels are unstable during pregnancy; 4) women who reported having had any type of cancer
other than breast cancer, to exclude the possibility of breast cancer as a secondary cancer; and 5) underweight women,
because disease-driven weight loss could perplex the analysis.

Outcome variable and covariates
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The outcome variable was age at death or censor (December 31, 2006). We controlled for breast cancer, BMI (selfreported), race, age at the time of survey, alcohol consumption, physical activity, and educational attainment. Breast
cancer information included breast cancer status and the duration from the time of diagnosis to that of the survey. For
women with no breast cancer diagnosis reported, the duration was recorded as zero. BMI classifications were based on
the standards established by the World Health Organization (19): overweight, BMI 25.0–29.9 kg/m2; class I obese,
BMI 30.0–34.9 kg/m2; class II obese, BMI 35.0–39.9 kg/m2; and class III obese, BMI 40 kg/m2 or higher. Normalweight women (BMI 18.5–24.9 kg/m2) were the reference group. Age at survey was described using 5 age categories:
30 to 39, 40 to 49, 50 to 59, 60 to 69, and 70 years or older. Age 30 or under was the reference category. For race,
dichotomized variables for whites and blacks were used. Racial groups other than whites and blacks were the reference
group. Interaction terms of breast cancer status with BMI, age, and racial groups were included as covariates.
The additional covariates were dichotomized as follows: educational attainment (whether a person was a high school
graduate); alcohol consumption (whether a person had had no more than 12 drinks of any type of alcoholic beverage in
the person’s entire life at time of survey); and physical activity (whether a person engaged in light/modest or vigorous
physical activity for at least 10 minutes more than once per week).

Statistical analysis
A survival model with Gamma frailty and Gompertz baseline was used (20). Maximum pseudo-likelihood estimation
was performed to adjust for complex sampling design in the NHIS data (21). The estimates were used to compute
hazard ratios for death (relative risks, RRs) (22) by BMI and racial groups for people with breast cancer and without
any cancer. Life years were predicted by a closed-form expression (23). The sample was divided into subsamples with
different combinations of race (whites, blacks, and other), age (aged <50 y, 50–69 y, and ≥70 y), and obesity status
(obese: class I–III; nonobese: normal weight and overweight). For each subsample, a sample was selected on the basis
of sampling weights, and life years were predicted on the basis of characteristics of the subsample. Within the same
subsample, the number of life years lost was projected by comparing the predicted life years of women with breast
cancer to the predicted life years of the same women had they not had breast cancer. The bootstrap method was
performed to resample the subpopulations 1,000 times to compute the means and standard errors (24).
All estimations and bootstraps were adjusted for the complex sampling design in the NHIS (25). Stata version 11 (Stata
Corp LP, College Station, Texas) was used to obtain the summary statistics for the sample and the population, and
Matlab version 7.13, R2012b (MathWorks Inc, Natick, Massachusetts) was used to perform estimations and
predictions.

Results
The initial sample size of women in our data was 70,651. The remaining sample after applying the exclusion criteria
consisted of 35,853 women, representing a US population estimated at 51,860,143 (95% confidence interval [CI],
50,944,982–52,775,304) nonsmoking adult women (aged ≥18 y) (Figure 1). Of the population, 78% were white and
14% were black (Table 1). The average BMI was 26.3 kg/m2 (Table 2); 50% of the population had normal weight; 28%
had a BMI within the overweight range; 14% belonged to class I obese; 5% belonged to class II obese; and 3% fell into
class III obese (Table 1).
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Figure. Data attrition diagram, study on obesity, mortality, and life years lost associated with breast cancer in
nonsmoking US women, National Health Interview Survey (NHIS), 1997–2000. [A text description of this figure is also
available.]
A total of 771 women in the sample (representing an estimated population of 1,058,767 [95% CI, 972,625–1,144,909])
reported having had a breast cancer diagnosis before the survey. The mean time from their cancer diagnosis to the
time of survey was 9.8 years (95% CI, 9.0–10.6) for the population (Table 2). The mean age of the population was 45
years (95% CI, 44.7–45.3). Breast cancer survivors were older on average (66.8 y; 95% CI, 65.6–67.9) than women who
did not report any cancer (44.6 y; 95% CI, 44.3–44.9). By 2006, a total of 3,104,152 (95% CI, 2,947,591–3,260,714) allcause deaths were estimated in this population (260,108 deaths for breast cancer survivors and 2,844,044 deaths for
women without any cancer). The mean age at death was estimated at 78.4 (95% CI, 76.5–80.4) for breast cancer
patients and 77.9 (95% CI, 77.2–78.6) for women without any cancer in the population.
We analyzed the adjusted relative risks of total mortality for women with breast cancer and without any cancer at
survey by BMI group. In the presence of breast cancer, relative risks increased with degree of obesity: 1.63 (95% CI,
1.28–2.07) for the class I obese, 2.66 (95% CI, 2.16–3.29) for the class II obese, and 8.49 (95% CI, 6.20–11.64) for the
class III obese. However, overweight women did not appear to be at an increased risk of mortality (RR, 0.90; 95% CI,
0.71–1.13). In the absence of any cancer, any degree of obesity increased mortality risk: 1.10 (95% CI, 1.07–1.13) for
overweight, 1.18 (95% CI, 1.14–1.21) for the class I obese, 1.90 (95% CI, 1.81–1.99) for the class II obese, and 2.88 (95%
CI, 2.72–3.06) for the class III obese.
The risk of mortality was higher for black women (RR, 1.29; 95% CI, 1.21–1.36) than for white women (RR, 0.88; 95%
CI, 0.83–0.93) when cancer was not reported. When breast cancer was reported, relative risks were 1.03 (95% CI, 0.82
–1.30) for whites and 1.59 (95% CI, 1.29–1.95) for blacks, compared with racial groups other than blacks and whites. It
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should be noted that some regression coefficients were not significant, possibly because of multicollinearity resulting
from adding interaction terms (26). However, the overall model fit was significant (F = 117.11, P value < .001).
Across all ages, obese (class I–III obese) women with breast cancer lost more life years than their nonobese (normalweight and overweight) counterparts. Obese whites lost 4.7 (95% CI, 4.1–5.3) life years; obese blacks lost 4.7 (95% CI,
3.0–6.4) years; and obese racial groups other than whites and blacks lost approximately 5.1 (95% CI, 2.9–7.4) life
years. Nonobese breast cancer patients lost fewer life years than their obese counterparts: 3.5 (95% CI, 3.1–3.9) years
for whites, 3.5 (95% CI, 2.2–4.8) years for blacks, and 4.0 (95% CI, 2.6–5.4) years for all other racial groups.
If breast cancer was present in obese women aged 50 or less, life years lost were 9.8 years (95% CI, 7.6–12.0) for
whites, 9.2 (95% CI, 6.4–12.0) for blacks, and 11.9 (95% CI, 5.7–18.0) for all other racial groups. Fewer life years were
lost for nonobese women aged 50 or less: 7.9 years (95% CI, 6.7–9.0) for whites, 5.3 (95% CI, 3.0–7.7) for blacks, and
6.0 (95% CI, 5.7–6.2) years for all other racial groups (Table 3). Obese women aged 50 through 69 lost more life years
associated with breast cancer than nonobese women of the same age: 3.8 years (95% CI, 3.0–4.7) for obese whites,
compared with 1.3 (95% CI, 0.6–2.0) for nonobese whites; 2.5 (95% CI, 0.97–4.1) for obese blacks, compared with 0.6
(95% CI, −1.4−2.6) for nonobese blacks; and 3.8 (95% CI, 2.3−5.2) for obese members of other racial groups compared
with 1.7 (95% CI, −0.2−3.7) for nonobese racial groups other than whites and blacks.
A similar trend was found among women aged 70 or older. For obese women aged 70 or older, the number of life years
lost was 4.9 (95% CI, 3.9−5.9) for whites and 6.9 (95% CI, 6.6−7.2) for blacks. With the exception of racial groups
other than whites and blacks, the number of life years lost was less for nonobese women aged 70 years or older: 3.7
(95% CI, 3.2−4.2) for whites, 4.5 (95% CI, 3.0−6.0) for blacks, and 5.8 (95% CI, 5.0−7.0) for all other racial groups.

Discussion
We used the following examples to translate life years lost associated with breast cancer to the proportion of total life
years. An obese white woman under age 50 with breast cancer was expected to lose 9.8 years of life, which translates to
a 12.1% reduction in the expected total life years (81.4 years) for a white woman aged 40 years (27). Similarly, an obese
black woman under age 50 with breast cancer was expected to lose 9.2 years of life, which translates to an 11.9%
reduction of the total life years (77.5 years) for a black woman aged 40 years (27).
No obvious racial disparity was found in life years lost associated with breast cancer between blacks and whites. Whites
(obese and nonobese) lost more life years than their black counterparts for age groups of under 50 and 50 to 69,
whereas black women aged 70 years or older lost more life years than white women of the same age range. A plausible
explanation is that our data showed fewer breast cancer cases in blacks than in whites and, on average, black women
have a higher prevalence of obesity and a shorter life expectancy than white women (1). Therefore, the extent to which
breast cancer shortened life years was not as prominent as the extent to which breast cancer increased mortality risk in
blacks. Wong et al (28) used a stochastic model to simulate life expectancy for blacks and whites. They found that, of
all cancers, breast cancer had the biggest impact on the racial difference in life years lost, accounting for 0.15 years (life
years lost for blacks minus that for whites), compared with 0.03 years for obese women and −0.05 years for nonobese
women at all ages in our study. The smaller gap between blacks and whites in our study was because the differences
were positive and wider for women aged 70 or older (1.94 years for obese women and 0.80 years for nonobese
women), whereas the differences were negative for women aged less than 70.
Previous studies that analyzed breast cancer mortality and BMI found results comparable to those of our study: higher
mortality among breast cancer patients with a higher degree of obesity. Reeves et al analyzed 1.2 million UK women
aged 50 to 64 from 1996 to 2001 and examined mortality from breast cancer in relation to BMI (10). Like us, they
found that increasing BMI was associated with a significant increase in the risk of breast cancer mortality. By using
data from 1997, Ni Mhurchu et al examined postmenopausal breast cancer mortality in New Zealand and found that
higher than optimal BMI (>21 kg/m2) contributed to postmenopausal breast cancer deaths (29); high BMI contributed
to 4% of cancer deaths, though the proportion of these deaths that was specific to breast cancer is unknown (29). Our
results with regard to mortality rate are consistent with those of Aragón et al, who found that premature mortality
attributable to breast cancer among San Francisco residents was the highest among black women compared with other
ethnic groups (Asians/Pacific Islanders, Latinos/Hispanics, and whites) (14). However, the predicted life years lost in
their study (13.4 years) was generally higher than that in ours, because we focused on nonsmoking women with no
other cancer reported at survey and controlled for several confounding variables.
Our study has several strengths. First, our analysis focused on breast cancer and examined its association with
mortality and life years, which has not been well studied and deserves more investigation (14,15). Second, the major
outcomes of our study are the basic metrics for population health and provide information about mortality and
longevity (16). Third, to our knowledge, ours is the first study to incorporate BMI, age, and race information in the
analysis of breast cancer, mortality, and life years lost. Fourth, our study advances methodology by controlling for
unobserved heterogeneity, allowing for a more precise estimation and prediction of life years lost. This is important for
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population studies, which lack information specific to breast cancer. Last, we used a national data set, and our
conclusions are generalizable to the population of US women.
This study has several limitations, many of which are due to secondary data constraints. First, breast cancer status was
dichotomized, preventing us from differentiating the extent of the disease progression or the effects of different types
of breast cancers. Second, the data contained few breast cancer cases for women aged less than 40 and for women
other than whites and blacks. The predicted life years lost for adult women under 50 and for racial groups other than
whites and blacks should be interpreted with this caveat in mind. Third, BMI information was self-reported and
recorded only at the time of survey, the latter of which restricted analyses of BMI and mortality at the diagnosis of
breast cancer. Fourth, the data used were cross-sectional, and our model is not time-varying and does not capture the
dynamics of disease evolution or weight change over time, limiting its projection capability on life years (30,31). Last,
our data does not capture menopausal status — shown to differentiate the associations of BMI with breast cancer
mortality risk (10) — but this limitation was compensated for by dividing the sample into 3 age groups (<50 y, 50−69
y, and ≥70 y). Future studies should focus on how the extent of breast cancer progression, different types of breast
cancers, treatments, or menopausal status affect the prediction of life years lost associated with breast cancer.
Our study suggests that breast cancer increased the risk of early mortality depending on degree of obesity and
decreased life years by 1 to 12 years depending on race, age, and obesity status. The number of life years lost associated
with breast cancer was higher for more obese women aged less than 50 than for nonobese women of the same age.
Moreover, obese women with breast cancer aged less than 50 and older than 70 bear a higher burden in terms of years
of life lost. Public health initiatives should put more emphasis on the prevention and control of obesity for these target
populations.
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Tables
Table 1. Descriptive Statistics for Nonsmoking US Women in the Sample
and the Population From the National Health Interview Survey, 1997–2000 a
Breast Cancer
Variable

n

N (SE)

No Cancer
n

1,058,767 (43,768) 35,082

N (SE)

Total
n

Total

771

All-cause death

208

260,108 (20,253)

White

661

924,138 (41,498) 25,941

Black

76

84,151 (9,755)

6,060

7,219,083 (202,540)

6,136

7,303,234 (205,566)

Other

34

50,478 (109,29)

3,081

4,122,602 (128,190)

3,115

41,73,080 (128,575)

2,438

50,801,376 (459,460) 35,853

N (SE)

2,844,044 (76,011)

51,860,143 (465,260)

2,646

3,104,152 (795,920)

39,459,691 (389,888) 26,602

40,383,829 (394,164)

Race

BMI groupb
Normal weight

315

433,178 (26,915) 16,859

25,531,527 (289,971) 17,174

25,964,705 (291,154)

Overweight

269

379,179 (28,156) 10,235

14,356,072 (196,833) 10,504

14,735,251 (201,082)

Class I obese

136

175,026 (16,906)

5,043

6,881,706 (124,430)

5,179

7,056,731 (125,298)

Class II obese

34

53,465 (9,871)

1,800

2,471,069 (73,607)

1,834

2,524,534 (73,495)

Class III obese

17

17,920 (4,738)

1,145

1,561,003 (57,872)

1,162

1,578,922 (58,002)

7

11,715 (5,337)

7,664

12,188,840 (207,881)

7,671

12,200,555 (208,345)

30–39

19

26,668 (6,681)

7,850

10,964,477 (160,630)

7,869

10,991,145 (160,655)

40–49

65

100,383 (14,445)

6,437

10,061,258 (176,813)

6,502

10,161,641 (177,674)

50–59

113

168,871 (19,351)

4,248

6,461,688 (122,378)

4,361

6,630,559 (123,705)

60–69

153

221,380 (18,495)

3,342

4,567,730 (99,367)

3,495

4,789,110 (103,801)

≥70

414

529,750 (28,844)

5,541

6,557,384 (129,219)

5,955

7,087,134 (136,195)

≥ High school graduate

585

821,615 (38,200) 27,156

41,660,054 (412,085) 27,741

42,481,669 (417,161)

< High school graduate

186

237,152 (20,158)

7,926

9,141,323 (174,170)

8,112

9,378,475 (174,589)

≤12 drinks

143

190,923 (17,843)

4,245

5,928,126 (118,714)

4,388

6,119,050 (119,701)

>12 drinks

628

867,844 (40,341) 30,837

44,873,250 (427,473) 31,465

45,741,094 (433,428)

Yes

303

451,699 (29,693) 16,760

26,152,738 (318,522) 17,063

26,604,438 (321,812)

No

468

607,068 (31,665) 18,322

24,648,638 (277,708) 18,790

25,255,706 (279,927)

Age group, y
<30

Educationc

Alcohol used

Physical activitye

Abbreviations: BMI: body mass index; SE: standard error.
a Data sources: National Health Interview Survey (NHIS), 1997–2000 and the NHIS Linked Mortality Public-Use Files.
b Normal weight: BMI 18.5–24.9 kg/m2; overweight: BMI 25.0–29.9 kg/m2; class I obese: BMI 30.0–34.9 kg/m2; class II
obese: BMI 35.0–39.9 kg/m2; class III obese: BMI ≥40 kg/m2.
c Whether an individual was a high school graduate.
d Whether a person had had no more than 12 drinks of any type of alcoholic beverage in the person’s entire life at time of
survey.
e Whether an individual engaged in light/modest or vigorous physical activity for at least 10 min more than once per week.
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Table 2. Continuous Variables for Nonsmoking US Women From the
National Health Interview Survey, 1997–2000
Breast Cancer
Variable

Sample
Mean

BMI, kg/m2

No Cancer

Population
Mean (SE)

Sample
Mean

Total

Population
Mean (SE)

Sample
Mean

Population
Mean (SE)

26.9

26.8 (0.18)

26.6

26.3 (0.04)

26.6

26.3 (0.04)

Duration from breast
cancer diagnosis to
survey, y

7.7

9.8 (0.42)

0.0

0.0

7.7

9.8 (0.42)

Mortality follow-up, y

6.7

8.5 (0.04)

7.3

8.5 (0.01)

7.3

8.5 (0.01)

Age at survey, y

67.8

66.8 (0.59)

46.8

44.6 (0.15)

47.3

45.0 (0.16)

Age at death, y

79.5

78.4 (0.97)

79.1

77.9 (0.35)

79.1

77.9 (0.33)

Abbreviations: BMI, body mass index; SE, standard error.

Table 3. Predicted Life Years Lost Associated With Breast Cancer for
Nonsmoking US Women by Obesity Status, Age, and Race, National Health
Interview Survey, 1997–2000 a
Obesity Status

Age, y

White, y (SE)

Black, y (SE)

Other, y (SE)

All

4.66 (0.31)

4.69 (0.85)

5.12 (1.16)

<50

9.77 (1.13)

9.22 (1.42)

11.85 (3.12)

50–69

3.84 (0.41)

2.52 (0.79)

3.75 (0.72)

≥70

4.93 (0.51)

6.87 (0.15)

5.17 (0)

All

3.53 (0.21)

3.48 (0.65)

3.97 (0.71)

<50

7.85 (0.61)

5.32 (1.22)

5.97 (0.13)

50–69

1.31 (0.35)

0.62 (1.02)

1.74 (0.99)

≥70

3.68 (0.25)

4.48 (0.78)

5.81 (0.62)

Obese

Nonobese

Abbreviations: SE: standard error.
a Data sources: National Health Interview Survey (NHIS), 1997–2000 and the NHIS Linked Mortality Public-Use Data Files.

Post-Test Information
To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the
following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and
earn continuing medical education (CME) credit, please go to http://www.medscape.org/journal/pcd . Credit
cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your
answers. You must be a registered user on Medscape.org. If you are not registered on Medscape.org, please click on the
“Register” link on the right hand side of the website to register. Only one answer is correct for each question. Once you
successfully answer all post-test questions you will be able to view and/or print your certificate. For questions
regarding the content of this activity, contact the accredited provider, CME@medscape.net. For technical assistance,
contact CME@webmd.net. American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are
accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to
http://www.ama-assn.org/ama/pub/about-ama/awards/ama-physicians-recognition-award.page . The AMA has
determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA
Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA
credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please
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complete the questions online, print the AMA PRA CME credit certificate and present it to your national medical
association for review.

Post-Test Questions
Article Title: Obesity, Mortality, and Life Years Lost Associated With Breast
Cancer in Nonsmoking US Women, National Health Interview Survey, 19972000
CME Questions
1. You are seeing a 48-year-old African American woman with newly diagnosed breast cancer. She has a history of
hyperlipidemia and a body mass index (BMI) of 36 kg/m2. Based on the current study by Dr. Chang and
colleagues, what can you tell this patient regarding the relationship between obesity and mortality among women
with breast cancer?
A. There was no relationship between obesity and the relative risk of mortality
B. Only underweight women were at higher risk for mortality
C. Only overweight, but not obese, women were at higher risk for mortality
D. There was an increasing risk for mortality associated with increasing classes of obesity
2. How did the risk of mortality associated with obesity compare among women with and without breast cancer?
A. Obesity was associated with a higher risk of mortality only among women with breast cancer
B. Obesity was associated with a higher risk of mortality only among women without breast cancer
C. Obesity increased the risk of death to a greater degree among women with breast cancer compared with those
without breast cancer
D. Obesity increased the risk of death to a greater degree among women without breast cancer compared with
those with breast cancer
3. According to the current study, what role does this patient’s age play in the relationship between obesity and her
risk of mortality?
A. Obesity was only associated with early mortality among women under 50 years old
B. Obesity was associated with the greatest number of life years lost among women under 50 years old
C. Obesity was only associated with early mortality among women aged 70 years or older
D. Obesity was associated with the greatest number of life years lost among women aged 70 years or older
4. According to the current study, what role does this patient’s race/ethnicity play in the relationship between
obesity and her risk of mortality?
A. Obesity resulted in a greater number of life years lost among black women vs white women
B. Obesity resulted in a greater number of life years lost among other racial/ethnic groups compared with black
and white women
C. Obesity only increased the risk of mortality among black women
D. Race/ethnicity did not affect the risk of mortality associated with obesity
Evaluation
1. The activity supported the learning objectives.
Strongly Disagree
1

Strongly Agree
2

3

4

5

2. The material was organized clearly for learning to occur.
Strongly Disagree
1

Strongly Agree
2

3

4

5

3. The content learned from this activity will impact my practice.
Strongly Disagree
1

Strongly Agree
2

3

4

5
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4. The activity was presented objectively and free of commercial bias.
Strongly Disagree
1
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2

3

4

5
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